Tapestry Pharmaceuticals to Sell Genomics Assets; Job Cuts to Total 25 Percent

Nov 19, 2004

NEW YORK, Nov. 18 (GenomeWeb News) - Tapestry Pharmaceuticals, formerlly known as NaPro BioTherapeutics, will close most of its genomics division by the end of next year, laying off around 20 people as it closes the division's facility and sells off or licenses out most of its assets, the firm said yesterday in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Hackers Go After Genome Data

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

What's This Personalized Medicine?

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

No Gene Drive Ban

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

This Week in Science

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Main menu